Turnstone Biologics Corp. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 96 rows, 96 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-07-25: Reporting owner Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2023-07-25: Reporting owner Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2023-07-25: Reporting owner Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2023-07-25: Reporting owner Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | C Conversion of derivative security | −7,897,999 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | C Conversion of derivative security | −601,077 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | C Conversion of derivative security | −263,349 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | C Conversion of derivative security | −237,575 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | C Conversion of derivative security | −3,530,789 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | C Conversion of derivative security | −268,711 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | C Conversion of derivative security | −117,730 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | C Conversion of derivative security | −106,208 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | C Conversion of derivative security | −7,650,043 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | C Conversion of derivative security | −582,206 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | C Conversion of derivative security | −255,081 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | C Conversion of derivative security | −230,117 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | C Conversion of derivative security | −1,119,729 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | C Conversion of derivative security | −85,217 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | C Conversion of derivative security | −37,283 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | C Conversion of derivative security | −33,682 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Versant Venture Capital V, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Vantage II GP, L.P. | Versant Vantage II, L.P. | Versant Venture Capital V (Canada), LP | Versant Ventures V, LLC | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By Versant Vantage II, L.P. | C Conversion of derivative security | −2,196,402 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | C Conversion of derivative security | −7,897,999 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | C Conversion of derivative security | −601,077 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | C Conversion of derivative security | −263,349 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | C Conversion of derivative security | −237,575 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | C Conversion of derivative security | −3,530,789 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | C Conversion of derivative security | −268,711 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | C Conversion of derivative security | −117,730 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | C Conversion of derivative security | −106,208 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | C Conversion of derivative security | −7,650,043 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | C Conversion of derivative security | −582,206 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | C Conversion of derivative security | −255,081 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | C Conversion of derivative security | −230,117 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | C Conversion of derivative security | −1,119,729 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | C Conversion of derivative security | −85,217 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | C Conversion of derivative security | −37,283 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | C Conversion of derivative security | −33,682 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | Jerel Davis Director, 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By Versant Vantage II, L.P. | C Conversion of derivative security | −2,196,402 0 owned after | $0.00 | 2023-07-27 | |
| 2023-07-25 | FMR LLC 10% Owner, Other (See Remark 1) | 4 | Series D Preferred Stock Derivative · Indirect · F-Prime Capital Partners Healthcare Fund V LP | C Conversion of derivative security | −91,663 0 owned after | no price filed | 2023-07-27 | |
| 2023-07-25 | FMR LLC 10% Owner, Other (See Remark 1) | 4 | Series C Preferred Stock Derivative · Indirect · F-Prime Capital Partners Healthcare Fund V LP | C Conversion of derivative security | −106,496 0 owned after | no price filed | 2023-07-27 | |
| 2023-07-25 | FMR LLC 10% Owner, Other (See Remark 1) | 4 | Series B-2 Preferred Stock Derivative · Indirect · F-Prime Capital Partners Healthcare Fund V LP | C Conversion of derivative security | −150,809 0 owned after | no price filed | 2023-07-27 | |
| 2023-07-25 | FMR LLC 10% Owner, Other (See Remark 1) | 4 | Series B-1 Preferred Stock Derivative · Indirect · F-Prime Capital Partners Healthcare Fund V LP | C Conversion of derivative security | −483,684 0 owned after | no price filed | 2023-07-27 | |
| 2023-07-25 | FMR LLC 10% Owner, Other (See Remark 1) | 4 | Series B-2 Preferred Stock Derivative · Indirect · Impresa Fund III Limited Partnership | C Conversion of derivative security | −296,396 0 owned after | no price filed | 2023-07-27 | |
| 2023-07-25 | FMR LLC 10% Owner, Other (See Remark 1) | 4 | Series B-2 Preferred Stock Derivative · Indirect · F-Prime Capital Partners Healthcare Advisors Fund V LP | C Conversion of derivative security | −4,939 0 owned after | no price filed | 2023-07-27 | |
| 2023-07-20 | Gupta Rishi Director, 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −937,372 0 owned after | no price filed | 2023-07-24 | |
| 2023-07-20 | Gupta Rishi Director, 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −1,249,829 0 owned after | no price filed | 2023-07-24 | |
| 2023-07-20 | Gupta Rishi Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −266,240 0 owned after | no price filed | 2023-07-24 | |
| 2023-07-20 | Gupta Rishi Director, 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −229,158 0 owned after | no price filed | 2023-07-24 | |
| 2023-07-20 | ORBIMED ADVISORS LLC | OrbiMed Capital GP VI LLC Director, 10% Owner | Director, 10% Owner | 4 | Series B-1 Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −937,372 0 owned after | no price filed | 2023-07-24 | |
| 2023-07-20 | ORBIMED ADVISORS LLC | OrbiMed Capital GP VI LLC Director, 10% Owner | Director, 10% Owner | 4 | Series B-2 Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −1,249,829 0 owned after | no price filed | 2023-07-24 | |
| 2023-07-20 | ORBIMED ADVISORS LLC | OrbiMed Capital GP VI LLC Director, 10% Owner | Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −266,240 0 owned after | no price filed | 2023-07-24 | |
| 2023-07-20 | ORBIMED ADVISORS LLC | OrbiMed Capital GP VI LLC Director, 10% Owner | Director, 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −229,158 0 owned after | no price filed | 2023-07-24 | |
| 2023-07-20 holding as of filing | Gupta Rishi Director, 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Gupta Rishi Director, 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Gupta Rishi Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Gupta Rishi Director, 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Jerel Davis Director, 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · By Versant Vantage II, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By Versant Venture Capital V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By Versant Venture Capital V (Canada) LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By Versant Ophthalmic Affiliates Fund I, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By Versant Affiliates Fund V, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | Versant Ophthalmic Affiliates I, L.P. | Versant Ventures V (Canada), L.P. | Versant Affiliates Fund V, L.P. | Versant Vantage II, L.P. | Versant Ventures V, LLC | Versant Vantage II GP, L.P. | Versant Ventures V GP-GP (Canada), Inc. | Versant Vantage II GP-GP, LLC | Versant Venture Capital V, L.P. | Versant Venture Capital V (Canada), LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · By Versant Vantage II, L.P. | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | OrbiMed Capital GP VI LLC | ORBIMED ADVISORS LLC Director, 10% Owner | Director, 10% Owner | 3 | Series B-1 Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | OrbiMed Capital GP VI LLC | ORBIMED ADVISORS LLC Director, 10% Owner | Director, 10% Owner | 3 | Series B-2 Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | OrbiMed Capital GP VI LLC | ORBIMED ADVISORS LLC Director, 10% Owner | Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | OrbiMed Capital GP VI LLC | ORBIMED ADVISORS LLC Director, 10% Owner | Director, 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | FMR LLC 10% Owner, Other (See Remark 1) | 3 | Series D Preferred Stock Derivative · Indirect · F-Prime Capital Partners Healthcare Fund V LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | FMR LLC 10% Owner, Other (See Remark 1) | 3 | Series C Preferred Stock Derivative · Indirect · F-Prime Capital Partners Healthcare Fund V LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | FMR LLC 10% Owner, Other (See Remark 1) | 3 | Series B-2 Preferred Stock Derivative · Indirect · F-Prime Capital Partners Healthcare Fund V LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | FMR LLC 10% Owner, Other (See Remark 1) | 3 | Series B-1 Preferred Stock Derivative · Indirect · F-Prime Capital Partners Healthcare Fund V LP | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | FMR LLC 10% Owner, Other (See Remark 1) | 3 | Series B-2 Preferred Stock Derivative · Indirect · Impresa Fund III Limited Partnership | Holding | no price filed | 2023-07-20 | ||
| 2023-07-20 holding as of filing | FMR LLC 10% Owner, Other (See Remark 1) | 3 | Series B-2 Preferred Stock Derivative · Indirect · F-Prime Capital Partners Healthcare Advisors Fund V LP | Holding | no price filed | 2023-07-20 |